Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi

Susanne Radke1, Harish Chander, Patrick Schäfer

  • 1Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.

Insights

Inhibiting the 26S proteasome causes mitochondrial changes and protein buildup. Mutant proteins are ubiquitinated, while wild-type proteins are cleared by Omi when the proteasome is blocked, impacting mitochondrial health.

Area of Science:

  • Cell Biology
  • Mitochondrial Biology
  • Neuroscience

Background:

  • The 26S proteasome is crucial for protein degradation.
  • Mitochondrial morphology and function are sensitive to proteasomal activity.
  • Intermembrane space (IMS) proteins play roles in mitochondrial homeostasis.

Purpose of the Study:

  • To investigate the impact of proteasome inhibition on mitochondrial morphology and IMS protein accumulation.
  • To elucidate the mechanisms of IMS protein degradation, particularly endonuclease G (endoG).
  • To explore the interplay between the proteasome, ubiquitination, and the mitochondrial protease Omi in protein quality control.

Main Methods:

  • Proteasome inhibition using specific inhibitors.
  • Morphological analysis of mitochondria.
  • Western blotting to detect protein ubiquitination and degradation.
  • Studying the role of endonuclease G (endoG) as a model IMS protein.
  • Investigating the activity of the mitochondrial protease Omi.

Main Results:

  • Proteasome inhibition leads to significant mitochondrial morphological changes and accumulation of IMS proteins.
  • Both wild-type and mutant endoG accumulate upon proteasome inhibition, with mutant endoG accumulating more extensively.
  • Wild-type and mutant endoG are substrates for ubiquitination, indicating a protein quality control pathway.
  • Wild-type endoG, but not mutant endoG, is degraded by Omi when the proteasome is inhibited.
  • These findings suggest a dual quality control mechanism for IMS proteins involving ubiquitination and Omi cleavage.

Conclusions:

  • Elimination of mutant IMS proteins relies on ubiquitination.
  • Excess or misfolded wild-type IMS proteins are managed by ubiquitination and Omi cleavage when proteasomal function is impaired.
  • Accumulation of IMS proteins due to impaired proteasomal function contributes to mitochondrial network collapse, relevant to neurodegenerative diseases.
  • Mutations in IMS proteins or Omi can accelerate mitochondrial collapse in conditions of compromised proteasome function.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...